Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- William T Carpenter, MD
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicien
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ezrath Nashim Association, Sarah Herzog Memorial Hospital
Jerusalem, Israel
- Ucla/va Greater Los Angeles Health Care System
Los Angeles, California, United States
- Maryland Psychiatric Research Center
Baltimore, Maryland, United States
- Zucker Hillside Hospital
Glen Oaks, New York, United States
- Nathan S Kline Institute for Psychiatric Research
Orangeburg, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2000
- Primary completion
- 30 Jun 2004
- Completion
- 30 Jun 2004
- Last update posted
- 20 Aug 2019
- Registered enrollment
- 240
- Registry id
- NCT00222235
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.